A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV

IntroductionThis study sought to explore the immunogenicity of a booster dose of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in people living with human immunodeficiency virus (HIV) and identify the factors affecting the magnitude of anti-SARS-CoV-2 antibody l...

Full description

Bibliographic Details
Main Authors: Zhengchao Lv, Songqin Lv, Qin Li, Yafei Xia, Zaineng Feng, Haohong Zhang, Haihao Yang, Zhao Wu, Nanting Zou, Qingyan Mo, Qianlan Gu, Sai Ying, Xicheng Wang, Dongdong Qin, Chunping Wan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Immunology
Subjects:
booster dose
inactivated SARS-CoV-2 vaccines
immunogenicity
T follicular helper cells
PLWH
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1264160/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1264160/full

Similar Items